Stock GXH GREEN CROSS HEALTH LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Green Cross Health Limited

Equities

GXH

NZBDOE0001S8

Drug Retailers

End-of-day quote New Zealand S.E.
Other stock markets
 06:00:00 2024-05-16 pm EDT 		5-day change 1st Jan Change
0.99 NZD 0.00% Intraday chart for Green Cross Health Limited -1.00% -9.17%
2023 Green Cross Health Limited Declares an Interim Dividend, Payable on 20 December 2023 CI
2023 Green Cross Health Limited Reports Earnings Results for the Half Year Ended September 30, 2023 CI

Valuation

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Capitalization 1 223.2 140.3 163.2 147.4 190.4 193.4
Enterprise Value (EV) 1 261.7 172.8 279.3 219.2 262.7 258
P/E ratio 13.5 x 8.73 x 12.1 x 8.81 x 7.78 x 4.29 x
Yield 4.38% 7.14% 3.07% - 4.89% 5.19%
Capitalization / Revenue 0.43 x 0.25 x 0.29 x 0.26 x 0.28 x 0.39 x
EV / Revenue 0.5 x 0.3 x 0.49 x 0.38 x 0.39 x 0.52 x
EV / EBITDA 7.26 x 5 x 6.9 x 5.5 x 4.43 x 6.54 x
EV / FCF 13.1 x 8.38 x 7.99 x 3.86 x 4.96 x 30.6 x
FCF Yield 7.65% 11.9% 12.5% 25.9% 20.2% 3.26%
Price to Book 1.89 x 1.13 x 1.31 x 1.04 x 1.19 x 1.01 x
Nbr of stocks (in thousands) 139,503 143,153 143,153 143,153 143,153 143,284
Reference price 2 1.600 0.9800 1.140 1.030 1.330 1.350
Announcement Date 5/30/18 5/29/19 7/24/20 5/28/21 5/27/22 5/30/23
1NZD in Million2NZD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net sales 1 522.9 567.2 568.5 570.4 670.3 493.6
EBITDA 1 36.03 34.54 40.48 39.86 59.28 39.43
EBIT 1 30.57 28.5 34.45 33.94 53.1 33.13
Operating Margin 5.85% 5.02% 6.06% 5.95% 7.92% 6.71%
Earnings before Tax (EBT) 1 29.56 27.43 23.64 28.93 48.04 27.1
Net income 1 16.78 16.1 13.49 16.75 24.56 45.23
Net margin 3.21% 2.84% 2.37% 2.94% 3.66% 9.16%
EPS 2 0.1185 0.1122 0.0941 0.1169 0.1710 0.3146
Free Cash Flow 1 20.03 20.63 34.95 56.74 53 8.421
FCF margin 3.83% 3.64% 6.15% 9.95% 7.91% 1.71%
FCF Conversion (EBITDA) 55.59% 59.73% 86.35% 142.35% 89.42% 21.36%
FCF Conversion (Net income) 119.34% 128.08% 259.1% 338.71% 215.81% 18.62%
Dividend per Share 2 0.0700 0.0700 0.0350 - 0.0650 0.0700
Announcement Date 5/30/18 5/29/19 7/24/20 5/28/21 5/27/22 5/30/23
1NZD in Million2NZD
Estimates

Balance Sheet Analysis

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net Debt 1 38.5 32.5 116 71.8 72.3 64.6
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) 1.068 x 0.9401 x 2.87 x 1.8 x 1.219 x 1.638 x
Free Cash Flow 1 20 20.6 35 56.7 53 8.42
ROE (net income / shareholders' equity) 17.7% 15.5% 12.6% 14.8% 20.9% 10.9%
ROA (Net income/ Total Assets) 7.64% 6.85% 6.71% 5.72% 8.58% 5.11%
Assets 1 219.7 235.1 200.9 292.8 286.3 885.6
Book Value Per Share 2 0.8400 0.8700 0.8700 0.9900 1.110 1.330
Cash Flow per Share 2 0.0800 0.1200 0.2400 0.2600 0.3200 0.4000
Capex 1 11.8 8.95 7.26 4.97 4.09 5.71
Capex / Sales 2.25% 1.58% 1.28% 0.87% 0.61% 1.16%
Announcement Date 5/30/18 5/29/19 7/24/20 5/28/21 5/27/22 5/30/23
1NZD in Million2NZD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Retail - Drugs without Grocery

1st Jan change Capi.
GREEN CROSS HEALTH LIMITED Stock Green Cross Health Limited
-9.17% 86.88M
RAIA DROGASIL S.A. Stock Raia Drogasil S.A.
-6.12% 9.25B
AIN HOLDINGS INC. Stock Ain Holdings Inc.
+32.54% 1.32B
QOL HOLDINGS CO., LTD. Stock Qol Holdings Co., Ltd.
-7.72% 361M
NIHON CHOUZAI CO.,LTD. Stock NIHON CHOUZAI Co.,Ltd.
+0.79% 269M
SALUS, LJUBLJANA, D. D. Stock SALUS, Ljubljana, d. d.
+12.22% 231M
PETMED EXPRESS, INC. Stock PetMed Express, Inc.
-39.42% 93.72M
MEDICAL IKKOU GROUP CO.,LTD. Stock Medical Ikkou Group Co.,Ltd.
+19.44% 59.62M
Retail - Drugs without Grocery
  1. Stock Market
  2. Equities
  3. GXH Stock
  4. Financials Green Cross Health Limited
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW